CD44 and breast cancer: Herein, we confirmed that miR-29a levels were not only increased in MCF-7 spheroid cells, CD44+/CD24− MCF-7 cells (BCSCs) and MDA-MB-231 cells compared with MCF-7 cells, but also in breast cancer tissues compared with corresponding distal non-cancerous tissues.